Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib MRI Study in Early RA
NCT01164579Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2010
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 2, randomised, double-blind trial of tofacitinib in rheumatoid arthritis (RA) (3 arms), sponsored by Pfizer. Primary endpoints: OMERACT RAMRIS Wrist and MCP Synovitis at 3 months and OMERACT RAMRIS Wrist and MCP Bone Marrow Edema at 6 months. Started Oct 2010; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01164579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01164579.